Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Other Manufacturing
(316/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Fatty liver
Nov 20, 2018
TARGET PharmaSolutions® to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead Sciences
Nov 13, 2018
Phase 2 Data for Galmed Pharmaceutical's Aramchol(TM) in Non-Alcoholic Steatohepatitis (NASH) Presented During Late-Breaking Abstract Oral Session of The Liver Meeting® 2018
Nov 12, 2018
NGM Bio Announces Preliminary Results from Phase 1b Study of NGM313 in Obese, Insulin Resistant Subjects with Nonalcoholic Fatty Liver Disease (NAFLD)
Nov 09, 2018
Predicting Clinical Outcomes With Multiparametric MRI Featuring Liver cT1 Equal to Biopsy, According to Research Presented at The Liver Meeting® 2018
Nov 09, 2018
NGM Bio Announces New Histology Data from Phase 2 Trial of NGM282 in Patients with NASH
Nov 06, 2018
NGM Bio Announces Multiple Presentations at AASLD's The Liver Meeting®, Including New NASH Histology Data from the Phase 2 Trial of NGM282 and Topline Phase 1b Data for NGM313
Nov 05, 2018
Lipocine Announces Completion of Enrollment in LPCN 1144 Liver Imaging Study in Subjects At-Risk for NASH
Oct 25, 2018
89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
Oct 24, 2018
TaiwanJ Pharmaceuticals Announces Positive Top-Line Results from Phase 2 Study of JKB-122 on Non-Alcoholic Fatty Liver Disease (NAFLD)
Oct 08, 2018
Viking Therapeutics Announces Data from In Vivo Study of VK2809 Presented at Oral Plenary Session of the 88th Annual Meeting of American Thyroid Association (ATA)
Oct 04, 2018
Viking Therapeutics Announces VK2809 Phase 2 Study Results Selected for Oral Late-Breaker Presentation at The Liver Meeting® 2018
Oct 01, 2018
Liver Cancer is on the Rise Despite Increasing Number of Treatments
Sep 18, 2018
Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol
Sep 13, 2018
Bird Rock Bio Completes Clinical Trial of Nimacimab in Patients with Fatty Liver Disease
Sep 05, 2018
Prometic to host Key Opinion Leader meeting on PBI-4050, a novel treatment for Alström Syndrome and promising therapeutic for non alcoholic steatohepatitis (NASH)
Aug 30, 2018
The Kinetix Group Partners with Rimidi to Launch a Clinical Care Partnership for the Management of Nonalcoholic Steatohepatitis (NASH)
Aug 23, 2018
The Nonalcoholic Steatohepatitis (NASH) Network in Collaboration with Echosens Launches a Real World Evidence Model
Aug 10, 2018
Prometic announces the publication of PBI-4050's antifibrotic activity in liver diseases in Journal of Pharmacology and Experimental Therapeutics
Jul 31, 2018
Large Population Imaging Study Reveals Utility of LiverMultiScan's Corrected T1 Measure as Potential Biomarker for Liver Health in Metabolic Diseases
Jul 05, 2018
HistoIndex Welcomes Its New CEO on Board
Page 1
››
Latest News
Apr 26, 2024
OpenGate Capital Completes Sale of SMAC
Apr 26, 2024
Masonite Shareholders Approve Transaction with Owens Corning
Apr 26, 2024
Avery Dennison Increases Quarterly Dividend
Apr 26, 2024
ComEd Joins Bronzeville Community to Unveil New Public EV Chargers
Apr 26, 2024
OCOchem Advances Hydrogen Formate Electrolyzer Process By 10x To Create World’s Largest Industrial Scale CO2...
Apr 26, 2024
Canada Tractors Industry Analysis & Forecasts 2023-2024 and 2029: Technological Advancements and Shift...
Apr 26, 2024
Global and Regional Aircraft Fuel Cells Industry Research 2023-2033: Integration into Aircraft Systems Drives...
Apr 26, 2024
Leeward Renewable Energy Releases Inaugural Sustainability Highlights Report
View all News
Agenda
24
September
Hilton London Syon Park, London, UK
Defence Transformation Conference
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
View All Events